Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
caspofungin acetate
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System
Phase:
Phase III
Type:
Supportive care
Status:
Approved-not yet active
Age:
16 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
A8851021
, NCT00806351
2.
A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-Seated Candida or Aspergillus Infections
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
20 months and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
2008_013
, MK0991-062, NCT00717860
3.
Phase II Study of Caspofungin Acetate as First-Line Therapy for Proven or Probable Invasive Aspergillosis in Patients With Hematologic Malignancies or in Patients Who Have Undergone Hematopoietic Stem Cell Transplantation
Phase:
Phase II
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
EORTC-65041
, EUDRACT-2004-002944-90, NCT00110045
4.
Phase II Study of Voriconazole and Caspofungin Acetate in Immunocompromised Patients With Invasive Fungal Infections
Phase:
Phase II
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
OHSU-HEM-0346-L
, OHSU-IRB-1379, NCT00238355
5.
Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis
Phase:
Phase II
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
Uni-Koeln-687
, EudraCT- No.: 2006-001936-30, NCT00404092
6.
Prophylaxis of Fungal Invasive Infections in Leukemia
Phase:
Phase II
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
2006-004432-70
, NCT00501098
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute